AbivaxCompany Details

Get alertedif Abivax gets funded!
Company description

L’ambition d’ABIVAX est de devenir un leader mondial des vaccins thérapeutiques et des médicaments antiviraux dont l’effet thérapeutique à long terme permet de traiter des maladies infectieuses graves comme le SIDA ou l’hépatite B chronique. ABIVAX est spécialisé dans la découverte et le développement de médicaments mais aussi dans leur commercialisation.


Funding history

DateDeal sizeInvestors 
October 14th, 2020$6,621,000Kreos CapitalView Deal
July 11th, 2019$13,500,000Sofinnova PartnersView Deal
September 28th, 2017UndisclosedKepler CheuvreuxView Deal
June 23rd, 2015$76,406,340-View Deal
Create alert
Want to know when Abivax gets funded?
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!